Recombinant interferon alpha-2 (Biocad)

重组干扰素α-2（Biocad）

Report date: 2022/02/09 09:40:16

Base Information

Drug NameRecombinant interferon alpha-2 (Biocad)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsCommunicable Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (NDA/BLA)

Highest Status in ChinaN/A

Originator CompaniesBIOCAD JSC

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBIOCAD JSC

Active IndicationsN/A

Inactive IndicationsCommunicable Diseases

ATC CodeN/A